Lavvan Inc.

Biotech firm Amyris Inc. (NASDAQ: AMRS) is clapping back at allegations made by Lavvan Inc. that it committed patent infringment. "Amyris is disappointed that LAVVAN has chosen the public domain to articulate its position," Amyris CEO John Melo said in a statement Friday. "...

Amyris Inc (NASDAQ: AMRS) shares were rallying Tuesday following the announcement of a cannabinoid development, licensing and commercialization agreement. What Happened Amyris, which produces ingredients in the health and wellness, clean beauty and flavors and fragrances markets, said it has...